Ranbaxy launches generic of Pioglitazone in US
Generics | News | By BioSpectrum Bureau | 0 Comment | 20 Aug, 2012
Bangalore: Ranbaxy Pharmaceuticals, a wholly owned subsidiary of Ranbaxy Laboratories, has launched authorized generic ...Read more
Abbott rejigs strategy, realigns India business
Generics | News | By BioSpectrum Bureau | 0 Comment | 12 Jul, 2013
Singapore: After acquiring the formulations business of India's Piramal Healthcare in 2010, US drug major Abbott Laborat...Read more
Chinese medicine firm Tianyin gets GMP certificate
Generics | News | By BioSpectrum Bureau | 0 Comment | 16 Sep, 2013
Singapore: China-based Tianyin Pharmaceutical (TPI) received GMP certification for its pre-extraction plant and formula...Read more
Natco wins patent dispute case against Teva
Generics | News | By BioSpectrum Bureau | 0 Comment | 04 Mar, 2014
Singapore: Based in India's Hyderabad, drug manufacturing major Natco Pharmaceuticals has won a long standing patent dis...Read more
Lilly to expand generics manufacturing facility in China
Generics | News | By BioSpectrum Bureau | 0 Comment | 06 Mar, 2014
Singapore: Lilly and Novast Laboratories have commenced the expansion of manufacturing and development facility capaciti...Read more
Ranbaxy to market infliximab biosimilar
Generics | News | By BioSpectrum Bureau | 0 Comment | 09 Jan, 2014
Singapore: Switzerland based EPIRUS, a wholly-owned subsidiary of Boston-based EPIRUS Biopharmaceuticals, and Ranbaxy La...Read more
US FDA issues API bulk & tapped density guidance
Generics | Regulatory | By BioSpectrum Bureau | 2 Comment | 11 Jul, 2013
Singapore: The US Food and Drug Administration (FDA) has issued guidance to the Active Pharmaceutical ingredient industr...Read more
Teva gets FDA nod for generics of Eli Lillys Evista
Generics | News | By BioSpectrum Bureau | 0 Comment | 05 Mar, 2014
Singapore: Teva Pharmaceutical has recieved USFDA approval of the generic equivalent to Evista (Raloxifene) Tablets, 60 ...Read more
Sun Pharma revenue touches $480 million in Q2 2012
Generics | Company results | By BioSpectrum Bureau | 8 Comment | 10 Aug, 2012
Mumbai: Sun Pharmaceutical Industries reported a growth of 62 percent in its net sales for the quarter ending June 30, 2...Read more
FIPB clears seven pharma proposals, defers three
Generics | Regulatory | By BioSpectrum Bureau | 3 Comment | 08 Jul, 2013
Singapore: The Foreign Investment Promotion Board (FIPB) has cleared seven out of the ten investment proposals in the ph...Read more
Australia temporarily bans 19 synthetic drugs
Generics | Regulatory | By BioSpectrum Bureau | 2 Comment | 21 Jun, 2013
Singapore: The Australian government has imposed a temporary ban on sales of 19 synthetic drugs pursuant to the product ...Read more
Generics market to touch $231 bn by 2017: Report
Generics | Analysis | By BioSpectrum Bureau | 2 Comment | 04 Jun, 2012
Singapore: The global generic pharmaceuticals market is likely to witness strong growth in the next few years owing to t...Read more
Bayer to acquire China's OTC firm
Generics | News | By BioSpectrum Bureau | 0 Comment | 28 Feb, 2014
Singapore: Bayer plans to acquire 100 percent of the shares of Dihon Pharmaceutical, a privately held pharmaceutical com...Read more
Actavis clocks $8.7 bn revenue in 2013
Generics | Company results | By BioSpectrum Bureau | 0 Comment | 21 Feb, 2014
Singapore: Global pharmaceutical company Actavis has clocked net revenue of $8.7 billion in the year 2013, marking an in...Read more
Indian market expected to grow 12% during 2011-15
Generics | News | By BioSpectrum Bureau | 0 Comment | 01 Aug, 2013
New Delhi: The global business intelligence firm, ResearchandMarket has filed their latest report with their projections...Read more
US court lifts temporary injunction against Hanmi
Generics | News | By BioSpectrum Bureau | 0 Comment | 03 Oct, 2013
Singapore: US Court of Appeals for the Federal Circuit (CAFC) has lifted a temporary injunction against the US launch of...Read more
Indian firms get FDA approval for 110 generic drugs
Generics | News | By BioSpectrum Bureau | 0 Comment | 16 Sep, 2013
Singapore: India pharmaceutical companies have yet again emerged as the biggest overseas sources of medicines sold in th...Read more
Simcere Pharma sells Boda subsidiary for $65 mn
Generics | News | By BioSpectrum Bureau | 0 Comment | 02 Jul, 2013
Singapore: Simcere Pharma has agreed to sell its 99.99 percent stake in Jilin Boda Pharma for $65 million. The company f...Read more